Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.Maria Mironova, Maria F. Lopes‐Virella, Gabriel Virella et al.|Diabetes|2000Cited by 97
Financial Benefits of a Hepatopancreaticobiliary ProgramAlexander S. Rosemurgy, Sharona Ross, Thomas W. Wood et al.|The American Surgeon|2016Cited by 3
The Evolving Landscape of Esophageal Cancer: A Four-Decade AnalysisAlexander S. Rosemurgy, Christian Rodriguez, Carrie E. Ryan et al.|The American Journal of Gastroenterology|2015Cited by 2